60 seconds with...Kathy Greenlee

Kathy Greenlee, U.S. Assistant Secretary for Aging
Kathy Greenlee, U.S. Assistant Secretary for Aging
Q: Your recent testimony before the Senate Aging Committee on the topic of Alzheimer's seemed especially earnest. True?

A: Helping older Americans who have Alzheimer's disease and related dementias maintain their dignity and independence is central to our mission. The Administration on Aging strongly supports embedding dementia practice into state long-term services and supports.

Q: What's AOA's involvement?

A: AOA works with [federal] research agencies to determine the universe of interventions that are suitable for ... community-based settings, where about three-quarters of persons with dementia live.

Q: What types of caregiver interventions are states testing?


A: One being translated by six states is the New York University Caregiver Intervention, a support program that significantly delayed institutionalization of persons with dementia by providing education, support and counseling to spousal caregivers. The average institutional delay was 557 days. (That) would result in an average savings of $121,983 in institutional costs per person.

Q: And this could free up government funds for other uses?

A: Early results indicate that [the six states'] projects are achieving some of the outcomes found in the original study. There are numerous other examples of success.
close

Next Article in News

More in News

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

Judge dismisses claims of 'nationwide' Medicare fraud in ...

Long-term care pharmacy Omnicare will not face charges that it engaged in "nationwide" Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the pharmacy still faces more ...

Long-term care providers should follow hospitals in adopting EHRs, government says ...

Healthcare providers have already exceeded the government's 2013 adoption goals for electronic health records, the Department of Health and Human Services announced Wednesday.

Five-day COPD treatment quells flare-ups, reduces side effects, researchers find

Patients with chronic obstructive pulmonary disease flare-ups do better with a shorter round of prednisone, researchers have found.